APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mosapride Citrate Tablets

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Mosapride Citrate Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025185 pages

Choose your research edition.

Industry ResearchMosapride Citrate Tablets Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Mosapride Citrate Tablets Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Mosapride Citrate Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mosapride Citrate Tablets Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Mosapride Citrate Tablets Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Mosapride Citrate Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Mosapride Citrate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Mosapride Citrate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Mosapride Citrate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Mosapride Citrate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Mosapride Citrate Tablets include Yabao Pharmaceutical Group Co., Ltd., Lunan Beite Pharmaceutical Co., Ltd., Jiangsu Hausen Pharmaceutical Group Co., Ltd., Guangdong Annuo Pharmaceutical Co., Ltd., Chengdu Kanghong Pharmaceutical Group Co., Ltd. and Sumitomo Pharma Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Mosapride Citrate Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Mosapride Citrate Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Mosapride Citrate Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Mosapride Citrate Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Mosapride Citrate Tablets Segment by Company

Yabao Pharmaceutical Group Co., Ltd.

Lunan Beite Pharmaceutical Co., Ltd.

Jiangsu Hausen Pharmaceutical Group Co., Ltd.

Guangdong Annuo Pharmaceutical Co., Ltd.

Chengdu Kanghong Pharmaceutical Group Co., Ltd.

Sumitomo Pharma Co., Ltd.

Mosapride Citrate Tablets Segment by Type

Original Drug

Generic Drug

Mosapride Citrate Tablets Segment by Application

Online Sales

Offline Sales

Mosapride Citrate Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mosapride Citrate Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mosapride Citrate Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mosapride Citrate Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Mosapride Citrate Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Mosapride Citrate Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Mosapride Citrate Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Mosapride Citrate Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Mosapride Citrate Tablets Industry Trends Table 2. Mosapride Citrate Tablets Industry Drivers Table 3. Mosapride Citrate Tablets Industry Opportunities and Challenges Table 4. Mosapride Citrate Tablets Industry Restraints Table 5. Global Mosapride Citrate Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Mosapride Citrate Tablets Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Mosapride Citrate Tablets Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Mosapride Citrate Tablets Sales Market Share by Manufacturers Table 9. Global Mosapride Citrate Tablets Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Mosapride Citrate Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Mosapride Citrate Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Mosapride Citrate Tablets Manufacturers, Product Type & Application Table 13. Global Mosapride Citrate Tablets Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Mosapride Citrate Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Original Drug Table 17. Major Manufacturers of Generic Drug Table 18. Global Mosapride Citrate Tablets Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Mosapride Citrate Tablets Sales by Type (2021-2026) & (K Units) Table 20. Global Mosapride Citrate Tablets Sales by Type (2027-2032) & (K Units) Table 21. Global Mosapride Citrate Tablets Sales Market Share by Type (2021-2026) Table 22. Global Mosapride Citrate Tablets Sales Market Share by Type (2027-2032) Table 23. Global Mosapride Citrate Tablets Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Mosapride Citrate Tablets Revenue by Type (2021-2026) & (K Units) Table 25. Global Mosapride Citrate Tablets Revenue by Type (2027-2032) & (K Units) Table 26. Global Mosapride Citrate Tablets Revenue Market Share by Type (2021-2026) Table 27. Global Mosapride Citrate Tablets Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Online Sales Table 29. Major Manufacturers of Offline Sales Table 30. Global Mosapride Citrate Tablets Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 31. Global Mosapride Citrate Tablets Sales by Application (2021-2026) & (K Units) Table 32. Global Mosapride Citrate Tablets Sales by Application (2027-2032) & (K Units) Table 33. Global Mosapride Citrate Tablets Sales Market Share by Application (2021-2026) Table 34. Global Mosapride Citrate Tablets Sales Market Share by Application (2027-2032) Table 35. Global Mosapride Citrate Tablets Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Mosapride Citrate Tablets Revenue by Application (2021-2026) & (K Units) Table 37. Global Mosapride Citrate Tablets Revenue by Application (2027-2032) & (K Units) Table 38. Global Mosapride Citrate Tablets Revenue Market Share by Application (2021-2026) Table 39. Global Mosapride Citrate Tablets Revenue Market Share by Application (2027-2032) Table 40. Global Mosapride Citrate Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 41. Global Mosapride Citrate Tablets Sales by Region (2021-2026) & (K Units) Table 42. Global Mosapride Citrate Tablets Sales Market Share by Region (2021-2026) Table 43. Global Mosapride Citrate Tablets Sales Forecasted by Region (2027-2032) & (K Units) Table 44. Global Mosapride Citrate Tablets Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Mosapride Citrate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 46. North America Mosapride Citrate Tablets Sales by Country (2021-2026) & (K Units) Table 47. North America Mosapride Citrate Tablets Sales by Country (2027-2032) & (K Units) Table 48. Europe Mosapride Citrate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. Europe Mosapride Citrate Tablets Sales by Country (2021-2026) & (K Units) Table 50. Europe Mosapride Citrate Tablets Sales by Country (2027-2032) & (K Units) Table 51. Asia Pacific Mosapride Citrate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Asia Pacific Mosapride Citrate Tablets Sales by Country (2021-2026) & (K Units) Table 53. Asia Pacific Mosapride Citrate Tablets Sales by Country (2027-2032) & (K Units) Table 54. South America, Middle East and Africa Mosapride Citrate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. South America, Middle East and Africa Mosapride Citrate Tablets Sales by Country (2021-2026) & (K Units) Table 56. South America, Middle East and Africa Mosapride Citrate Tablets Sales by Country (2027-2032) & (K Units) Table 57. Global Mosapride Citrate Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Mosapride Citrate Tablets Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Mosapride Citrate Tablets Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Mosapride Citrate Tablets Revenue Market Share by Region (2021-2026) Table 61. Global Mosapride Citrate Tablets Revenue Market Share by Region (2027-2032) Table 62. Yabao Pharmaceutical Group Co., Ltd. Company Information Table 63. Yabao Pharmaceutical Group Co., Ltd. Business Overview Table 64. Yabao Pharmaceutical Group Co., Ltd. Mosapride Citrate Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Yabao Pharmaceutical Group Co., Ltd. Mosapride Citrate Tablets Product Portfolio Table 66. Yabao Pharmaceutical Group Co., Ltd. Recent Development Table 67. Lunan Beite Pharmaceutical Co., Ltd. Company Information Table 68. Lunan Beite Pharmaceutical Co., Ltd. Business Overview Table 69. Lunan Beite Pharmaceutical Co., Ltd. Mosapride Citrate Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Lunan Beite Pharmaceutical Co., Ltd. Mosapride Citrate Tablets Product Portfolio Table 71. Lunan Beite Pharmaceutical Co., Ltd. Recent Development Table 72. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Company Information Table 73. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Business Overview Table 74. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Mosapride Citrate Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Mosapride Citrate Tablets Product Portfolio Table 76. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Recent Development Table 77. Guangdong Annuo Pharmaceutical Co., Ltd. Company Information Table 78. Guangdong Annuo Pharmaceutical Co., Ltd. Business Overview Table 79. Guangdong Annuo Pharmaceutical Co., Ltd. Mosapride Citrate Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Guangdong Annuo Pharmaceutical Co., Ltd. Mosapride Citrate Tablets Product Portfolio Table 81. Guangdong Annuo Pharmaceutical Co., Ltd. Recent Development Table 82. Chengdu Kanghong Pharmaceutical Group Co., Ltd. Company Information Table 83. Chengdu Kanghong Pharmaceutical Group Co., Ltd. Business Overview Table 84. Chengdu Kanghong Pharmaceutical Group Co., Ltd. Mosapride Citrate Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Chengdu Kanghong Pharmaceutical Group Co., Ltd. Mosapride Citrate Tablets Product Portfolio Table 86. Chengdu Kanghong Pharmaceutical Group Co., Ltd. Recent Development Table 87. Sumitomo Pharma Co., Ltd. Company Information Table 88. Sumitomo Pharma Co., Ltd. Business Overview Table 89. Sumitomo Pharma Co., Ltd. Mosapride Citrate Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Sumitomo Pharma Co., Ltd. Mosapride Citrate Tablets Product Portfolio Table 91. Sumitomo Pharma Co., Ltd. Recent Development Table 92. Key Raw Materials Table 93. Raw Materials Key Suppliers Table 94. Mosapride Citrate Tablets Distributors List Table 95. Mosapride Citrate Tablets Customers List Table 96. Research Programs/Design for This Report Table 97. Authors List of This Report Table 98. Secondary Sources Table 99. Primary Sources List of Figures Figure 1. Mosapride Citrate Tablets Product Image Figure 2. Global Mosapride Citrate Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mosapride Citrate Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Mosapride Citrate Tablets Sales (2021-2032) & (K Units) Figure 5. Global Mosapride Citrate Tablets Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Mosapride Citrate Tablets Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Original Drug Image Figure 9. Generic Drug Image Figure 10. Global Mosapride Citrate Tablets Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Mosapride Citrate Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Mosapride Citrate Tablets Sales Market Share by Type (2021-2032) Figure 13. Global Mosapride Citrate Tablets Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Mosapride Citrate Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Mosapride Citrate Tablets Revenue Market Share by Type (2021-2032) Figure 16. Online Sales Image Figure 17. Offline Sales Image Figure 18. Global Mosapride Citrate Tablets Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Mosapride Citrate Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Mosapride Citrate Tablets Sales Market Share by Application (2021-2032) Figure 21. Global Mosapride Citrate Tablets Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Mosapride Citrate Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Mosapride Citrate Tablets Revenue Market Share by Application (2021-2032) Figure 24. North America Mosapride Citrate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 25. North America Mosapride Citrate Tablets Sales Market Share by Country (2021-2032) Figure 26. U.S. Mosapride Citrate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 27. Canada Mosapride Citrate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Mexico Mosapride Citrate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Europe Mosapride Citrate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Mosapride Citrate Tablets Sales Market Share by Country (2021-2032) Figure 31. Germany Mosapride Citrate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 32. France Mosapride Citrate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 33. U.K. Mosapride Citrate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Italy Mosapride Citrate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Netherlands Mosapride Citrate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Asia Pacific Mosapride Citrate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Mosapride Citrate Tablets Sales Market Share by Country (2021-2032) Figure 38. China Mosapride Citrate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Japan Mosapride Citrate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 40. South Korea Mosapride Citrate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Southeast Asia Mosapride Citrate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 42. India Mosapride Citrate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Australia Mosapride Citrate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South America, Middle East and Africa Mosapride Citrate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Mosapride Citrate Tablets Sales Market Share by Country (2021-2032) Figure 46. Brazil Mosapride Citrate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Africa Mosapride Citrate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Saudi Arabia Mosapride Citrate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Turkey Mosapride Citrate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Argentina Mosapride Citrate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 51. UAE Mosapride Citrate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Egypt Mosapride Citrate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Chile Mosapride Citrate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Global Mosapride Citrate Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Mosapride Citrate Tablets Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Mosapride Citrate Tablets Revenue (2021-2032) & (US$ Million) Figure 57. North America Mosapride Citrate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Mosapride Citrate Tablets Revenue (2021-2032) & (US$ Million) Figure 59. Europe Mosapride Citrate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Mosapride Citrate Tablets Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Mosapride Citrate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Mosapride Citrate Tablets Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Mosapride Citrate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Mosapride Citrate Tablets Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Mosapride Citrate Tablets Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Original Drug
  • Generic Drug
Applications
  • Online Sales
  • Offline Sales
Companies covered
  • Yabao Pharmaceutical Group Co., Ltd.
  • Lunan Beite Pharmaceutical Co., Ltd.
  • Jiangsu Hausen Pharmaceutical Group Co., Ltd.
  • Guangdong Annuo Pharmaceutical Co., Ltd.
  • Chengdu Kanghong Pharmaceutical Group Co., Ltd.
  • Sumitomo Pharma Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Mosapride Citrate Tablets Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Mosapride Citrate Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Mosapride Citrate Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Mosapride Citrate Tablets Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Mosapride Citrate Tablets Market Dynamics
  1. 2.1 Mosapride Citrate Tablets Industry Trends
  2. 2.2 Mosapride Citrate Tablets Industry Drivers
  3. 2.3 Mosapride Citrate Tablets Industry Opportunities and Challenges
  4. 2.4 Mosapride Citrate Tablets Industry Restraints
3 Mosapride Citrate Tablets Market by Manufacturers
  1. 3.1 Global Mosapride Citrate Tablets Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Mosapride Citrate Tablets Sales by Manufacturers (2021-2026)
  3. 3.3 Global Mosapride Citrate Tablets Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Mosapride Citrate Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Mosapride Citrate Tablets Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Mosapride Citrate Tablets Manufacturers, Product Type & Application
  7. 3.7 Global Mosapride Citrate Tablets Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Mosapride Citrate Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Mosapride Citrate Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Mosapride Citrate Tablets Tier 1, Tier 2, and Tier 3
4 Mosapride Citrate Tablets Market by Type
  1. 4.1 Mosapride Citrate Tablets Type Introduction
  2. 4.1.1 Original Drug
  3. 4.1.2 Generic Drug
  4. 4.2 Global Mosapride Citrate Tablets Sales by Type
  5. 4.2.1 Global Mosapride Citrate Tablets Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Mosapride Citrate Tablets Sales by Type (2021-2032)
  7. 4.2.3 Global Mosapride Citrate Tablets Sales Market Share by Type (2021-2032)
  8. 4.3 Global Mosapride Citrate Tablets Revenue by Type
  9. 4.3.1 Global Mosapride Citrate Tablets Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Mosapride Citrate Tablets Revenue by Type (2021-2032)
  11. 4.3.3 Global Mosapride Citrate Tablets Revenue Market Share by Type (2021-2032)
5 Mosapride Citrate Tablets Market by Application
  1. 5.1 Mosapride Citrate Tablets Application Introduction
  2. 5.1.1 Online Sales
  3. 5.1.2 Offline Sales
  4. 5.2 Global Mosapride Citrate Tablets Sales by Application
  5. 5.2.1 Global Mosapride Citrate Tablets Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Mosapride Citrate Tablets Sales by Application (2021-2032)
  7. 5.2.3 Global Mosapride Citrate Tablets Sales Market Share by Application (2021-2032)
  8. 5.3 Global Mosapride Citrate Tablets Revenue by Application
  9. 5.3.1 Global Mosapride Citrate Tablets Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Mosapride Citrate Tablets Revenue by Application (2021-2032)
  11. 5.3.3 Global Mosapride Citrate Tablets Revenue Market Share by Application (2021-2032)
6 Global Mosapride Citrate Tablets Sales by Region
  1. 6.1 Global Mosapride Citrate Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Mosapride Citrate Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Mosapride Citrate Tablets Sales by Region (2021-2026)
  4. 6.2.2 Global Mosapride Citrate Tablets Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Mosapride Citrate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Mosapride Citrate Tablets Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Mosapride Citrate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Mosapride Citrate Tablets Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Mosapride Citrate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Mosapride Citrate Tablets Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Mosapride Citrate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Mosapride Citrate Tablets Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Mosapride Citrate Tablets Revenue by Region
  1. 7.1 Global Mosapride Citrate Tablets Revenue by Region
  2. 7.1.1 Global Mosapride Citrate Tablets Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Mosapride Citrate Tablets Revenue by Region (2021-2026)
  4. 7.1.3 Global Mosapride Citrate Tablets Revenue by Region (2027-2032)
  5. 7.1.4 Global Mosapride Citrate Tablets Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Mosapride Citrate Tablets Revenue (2021-2032)
  8. 7.2.2 North America Mosapride Citrate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Mosapride Citrate Tablets Revenue (2021-2032)
  11. 7.3.2 Europe Mosapride Citrate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Mosapride Citrate Tablets Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Mosapride Citrate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Mosapride Citrate Tablets Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Mosapride Citrate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Yabao Pharmaceutical Group Co., Ltd.
  2. 8.1.1 Yabao Pharmaceutical Group Co., Ltd. Company Information
  3. 8.1.2 Yabao Pharmaceutical Group Co., Ltd. Business Overview
  4. 8.1.3 Yabao Pharmaceutical Group Co., Ltd. Mosapride Citrate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Yabao Pharmaceutical Group Co., Ltd. Mosapride Citrate Tablets Product Portfolio
  6. 8.1.5 Yabao Pharmaceutical Group Co., Ltd. Recent Developments
  7. 8.2 Lunan Beite Pharmaceutical Co., Ltd.
  8. 8.2.1 Lunan Beite Pharmaceutical Co., Ltd. Company Information
  9. 8.2.2 Lunan Beite Pharmaceutical Co., Ltd. Business Overview
  10. 8.2.3 Lunan Beite Pharmaceutical Co., Ltd. Mosapride Citrate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Lunan Beite Pharmaceutical Co., Ltd. Mosapride Citrate Tablets Product Portfolio
  12. 8.2.5 Lunan Beite Pharmaceutical Co., Ltd. Recent Developments
  13. 8.3 Jiangsu Hausen Pharmaceutical Group Co., Ltd.
  14. 8.3.1 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Company Information
  15. 8.3.2 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Business Overview
  16. 8.3.3 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Mosapride Citrate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Mosapride Citrate Tablets Product Portfolio
  18. 8.3.5 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Recent Developments
  19. 8.4 Guangdong Annuo Pharmaceutical Co., Ltd.
  20. 8.4.1 Guangdong Annuo Pharmaceutical Co., Ltd. Company Information
  21. 8.4.2 Guangdong Annuo Pharmaceutical Co., Ltd. Business Overview
  22. 8.4.3 Guangdong Annuo Pharmaceutical Co., Ltd. Mosapride Citrate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Guangdong Annuo Pharmaceutical Co., Ltd. Mosapride Citrate Tablets Product Portfolio
  24. 8.4.5 Guangdong Annuo Pharmaceutical Co., Ltd. Recent Developments
  25. 8.5 Chengdu Kanghong Pharmaceutical Group Co., Ltd.
  26. 8.5.1 Chengdu Kanghong Pharmaceutical Group Co., Ltd. Company Information
  27. 8.5.2 Chengdu Kanghong Pharmaceutical Group Co., Ltd. Business Overview
  28. 8.5.3 Chengdu Kanghong Pharmaceutical Group Co., Ltd. Mosapride Citrate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Chengdu Kanghong Pharmaceutical Group Co., Ltd. Mosapride Citrate Tablets Product Portfolio
  30. 8.5.5 Chengdu Kanghong Pharmaceutical Group Co., Ltd. Recent Developments
  31. 8.6 Sumitomo Pharma Co., Ltd.
  32. 8.6.1 Sumitomo Pharma Co., Ltd. Company Information
  33. 8.6.2 Sumitomo Pharma Co., Ltd. Business Overview
  34. 8.6.3 Sumitomo Pharma Co., Ltd. Mosapride Citrate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sumitomo Pharma Co., Ltd. Mosapride Citrate Tablets Product Portfolio
  36. 8.6.5 Sumitomo Pharma Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Mosapride Citrate Tablets Value Chain Analysis
  2. 9.1.1 Mosapride Citrate Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Mosapride Citrate Tablets Production Mode & Process
  6. 9.2 Mosapride Citrate Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Mosapride Citrate Tablets Distributors
  9. 9.2.3 Mosapride Citrate Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst